4.8 Article

Electronic cigarettes versus nicotine patches for smoking cessation in pregnancy: a randomized controlled trial

期刊

NATURE MEDICINE
卷 28, 期 5, 页码 958-+

出版社

NATURE PORTFOLIO
DOI: 10.1038/s41591-022-01808-0

关键词

-

资金

  1. National Institute of Health Research, Health Technology Programme [15/57/85]

向作者/读者索取更多资源

A randomized controlled trial comparing electronic cigarettes and nicotine patches for smoking cessation in pregnant women found no significant differences between the two interventions. However, when analyzing the data from pregnant women who strictly followed the trial protocol, electronic cigarettes were found to be beneficial.
A randomized controlled trial comparing the efficacy of electronic cigarettes and nicotine patches for smoking cessation in pregnant women found no differences between the interventions. However, electronic cigarettes were found to have some benefit when only the data from women who adhered strictly to the trial protocol were analyzed. Nicotine replacement therapy, in the form of nicotine patches, is commonly offered to pregnant women who smoke to help them to stop smoking, but this approach has limited efficacy in this population. Electronic cigarettes (e-cigarettes) are also used by pregnant women who smoke but their safety and efficacy in pregnancy are unknown. Here, we report the results of a randomized controlled trial in 1,140 participants comparing refillable e-cigarettes with nicotine patches. Pregnant women who smoked were randomized to e-cigarettes (n = 569) or nicotine patches (n = 571). In the unadjusted analysis of the primary outcome, validated prolonged quit rates at the end of pregnancy in the two study arms were not significantly different (6.8% versus 4.4% in the e-cigarette and patch arms, respectively; relative risk (RR) = 1.55, 95%CI: 0.95-2.53, P = 0.08). However, some participants in the nicotine patch group also used e-cigarettes during the study. In a pre-specified sensitivity analysis excluding abstinent participants who used non-allocated products, e-cigarettes were more effective than patches (6.8% versus 3.6%; RR = 1.93, 95%CI: 1.14-3.26, P = 0.02). Safety outcomes included adverse events and maternal and birth outcomes. The safety profile was found to be similar for both study products, however, low birthweight (<2,500 g) was less frequent in the e-cigarette arm (14.8% versus 9.6%; RR = 0.65, 95%CI: 0.47-0.90, P = 0.01). Other adverse events and birth outcomes were similar in the two study arms. E-cigarettes might help women who are pregnant to stop smoking, and their safety for use in pregnancy is similar to that of nicotine patches. ISRCTN62025374.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据